ShA early titration

The total sum of the number of infusions taken in the last hour of days 1-3 of short access

Tags: Behavior · Cocaine

Project: u01_olivier_george_cocaine

4 loci · 4 genes with independent associations · 4 total associated genes

Significant Loci

# Chr Start pos End pos # assoc genes # joint models Best TWAS P Best GWAS P Cond GWAS P Joint genes
1 chr7 92127461 93066096 1 1 3.75e-10 5.98e-01 1.0e+00 Ndufb9
2 chr8 117463629 118343328 1 1 3.43e-09 2.88e-01 1.0e+00 Mst1
3 chr9 83390749 84777604 1 1 0.00e+00 8.89e-02 1.0e+00 Retreg2
4 chr17 61510864 62906219 1 1 5.75e-22 1.80e-01 2.3e-02 Ccny

Pleiotropic Associations

Trait Chi2 ratio # genes+ # genes++ % genes++ Corr Corr P Genes
BMI with tail 439.52 2 2 50 0 1.00e+00 Ndufb9 Retreg2
BMI without tail 19087.71 3 2 50 0 1.00e+00 Ccny Ndufb9 Retreg2
Body weight 8.94 3 2 50 0 1.00e+00 Mst1 Ndufb9 Retreg2
Epididymis fat weight 9080.51 4 3 75 -1 5.44e-04 Ccny Mst1 Ndufb9 Retreg2
Glucose 226.07 3 2 50 0 1.00e+00 Mst1 Ndufb9 Retreg2
Heart weight 1536.76 2 1 25 0 1.00e+00 Ndufb9 Retreg2
Left kidney weight 18352.54 3 2 50 0 1.00e+00 Ccny Ndufb9 Retreg2
Right kidney weight 10109.45 4 4 100 1 1.94e-03 Ccny Mst1 Ndufb9 Retreg2
Tail length 9640.98 3 1 25 0 1.00e+00 Mst1 Ndufb9 Retreg2
Length with tail 501.6 3 3 75 0 1.00e+00 Mst1 Ndufb9 Retreg2
Length without tail 11815.62 4 2 50 1 1.79e-03 Ccny Mst1 Ndufb9 Retreg2
Liver weight, left 880.75 4 2 50 1 6.83e-04 Ccny Mst1 Ndufb9 Retreg2
Liver weight, right 31.51 3 2 50 0 1.00e+00 Mst1 Ndufb9 Retreg2
Parametrial fat weight 181.56 1 1 25 0 1.00e+00 Retreg2
Retroperitoneal fat weight 1985.63 2 2 50 0 1.00e+00 Mst1 Retreg2
Intraocular pressure 5195.51 2 1 25 0 1.00e+00 Ndufb9 Retreg2
Extensor digitorum longus weight 541.05 2 1 25 0 1.00e+00 Mst1 Retreg2
Soleus weight 9.26 3 1 25 0 1.00e+00 Mst1 Ndufb9 Retreg2
Tibialis anterior weight 580.28 2 1 25 0 1.00e+00 Mst1 Retreg2
Tibia length 265.42 3 2 50 0 1.00e+00 Mst1 Ndufb9 Retreg2
Number of licking bursts 67424.86 1 1 25 0 1.00e+00 Retreg2
Food consumed during 24 hour testing period 11843.69 3 1 25 0 1.00e+00 Ccny Mst1 Retreg2
Times rat made contact with spout 41.61 2 1 25 0 1.00e+00 Ndufb9 Retreg2
Mean time between licks in bursts 55817.09 2 1 25 0 1.00e+00 Ndufb9 Retreg2
Mean num. licks in bursts 56750.08 1 1 25 0 1.00e+00 Retreg2
Std. dev. time between licks in bursts 14881.26 2 1 25 0 1.00e+00 Mst1 Retreg2
Water consumed over 24 hours 11394.32 3 1 25 0 1.00e+00 Ccny Mst1 Retreg2
Patch foraging indifference point 0 sec 19591.07 2 1 25 0 1.00e+00 Mst1 Retreg2
Patch foraging indifference point AUC 12566.41 4 3 75 1 1.92e-03 Ccny Mst1 Ndufb9 Retreg2
Indifference point function ln k 13972.7 4 4 100 -1 1.20e-03 Ccny Mst1 Ndufb9 Retreg2
Indifference point function log k 13972.7 4 4 100 -1 1.20e-03 Ccny Mst1 Ndufb9 Retreg2
Patch foraging total patch changes 0 sec 20977.37 2 1 25 0 1.00e+00 Mst1 Retreg2
Patch foraging total patch changes 12 sec 612.51 4 4 100 -1 4.52e-03 Ccny Mst1 Ndufb9 Retreg2
Patch foraging total patch changes 18 sec 10122.69 4 2 50 -1 3.12e-03 Ccny Mst1 Ndufb9 Retreg2
Patch foraging total patch changes 24 sec 18737.98 4 3 75 -1 4.01e-03 Ccny Mst1 Ndufb9 Retreg2
Patch foraging total patch changes 6 sec 1956.8 4 2 50 -1 2.02e-03 Ccny Mst1 Ndufb9 Retreg2
Patch foraging time to switch 0 sec 22171.85 3 2 50 0 1.00e+00 Mst1 Ndufb9 Retreg2
Patch foraging water rate 0 sec 30219.01 2 1 25 0 1.00e+00 Ndufb9 Retreg2
Patch foraging water rate 12 sec 23555.93 3 2 50 0 1.00e+00 Ccny Mst1 Retreg2
Patch foraging water rate 18 sec 11246.65 3 1 25 0 1.00e+00 Mst1 Ndufb9 Retreg2
Patch foraging water rate 24 sec 523.92 2 1 25 0 1.00e+00 Mst1 Retreg2
Patch foraging water rate 6 sec 297.7 3 3 75 0 1.00e+00 Ccny Ndufb9 Retreg2
Locomotor activity 16.04 3 1 25 0 1.00e+00 Ccny Mst1 Ndufb9
Locomotor testing distance 6934.02 4 3 75 0.99 8.29e-03 Ccny Mst1 Ndufb9 Retreg2
Locomotor testing rearing 21145.02 3 2 50 0 1.00e+00 Mst1 Ndufb9 Retreg2
Light reinforcement 1 22114.5 3 2 50 0 1.00e+00 Ccny Mst1 Retreg2
Light reinforcement 2 9210.73 4 3 75 1 9.62e-04 Ccny Mst1 Ndufb9 Retreg2
Reaction time number correct 21165.65 3 2 50 0 1.00e+00 Ccny Ndufb9 Retreg2
Reaction time mean minus median 39986.09 3 1 25 0 1.00e+00 Mst1 Ndufb9 Retreg2
Reaction time mean minus median AUC 41341.25 3 3 75 0 1.00e+00 Mst1 Ndufb9 Retreg2
Reaction time num false alarms 7685.9 2 1 25 0 1.00e+00 Mst1 Retreg2
Reaction time num false alarms AUC 11677.34 3 1 25 0 1.00e+00 Ccny Mst1 Retreg2
Reaction time trials correct on left 21165.65 3 2 50 0 1.00e+00 Ccny Ndufb9 Retreg2
Reaction time trials on left 20303.42 3 2 50 0 1.00e+00 Ccny Ndufb9 Retreg2
Reaction time mean 29724.21 1 1 25 0 1.00e+00 Retreg2
Reaction time mean AUC 38768 1 1 25 0 1.00e+00 Retreg2
Median of all reaction times 7893.84 1 1 25 0 1.00e+00 Retreg2
Reaction time omissions 2792.39 3 1 25 0 1.00e+00 Mst1 Ndufb9 Retreg2
Reaction time false alarm rate 76.38 3 1 25 0 1.00e+00 Mst1 Ndufb9 Retreg2
Reaction time premature initiation rate 9733.76 1 1 25 0 1.00e+00 Retreg2
Reaction time premature initiations 53743.58 1 1 25 0 1.00e+00 Retreg2
Std. dev. reaction times 20293.6 3 1 25 0 1.00e+00 Mst1 Ndufb9 Retreg2
Reaction time trials completed 20303.42 3 2 50 0 1.00e+00 Ccny Ndufb9 Retreg2
Reaction time trials AUC 20718.27 3 1 25 0 1.00e+00 Ccny Ndufb9 Retreg2
Social response proportion 4397.95 2 1 25 0 1.00e+00 Mst1 Retreg2
Social responses 323.05 4 1 25 1 1.45e-03 Ccny Mst1 Ndufb9 Retreg2
Social time 5828.31 2 1 25 0 1.00e+00 Mst1 Retreg2
Conditioned locomotion 1400.08 1 1 25 0 1.00e+00 Retreg2
Cocaine response after cond. corrected 19128.47 1 1 25 0 1.00e+00 Retreg2
Cocaine response after cond. not corrected 18571.31 1 1 25 0 1.00e+00 Retreg2
Cocaine response before conditioning 655.41 1 1 25 0 1.00e+00 Retreg2
Saline control response 1639.18 2 2 50 0 1.00e+00 Mst1 Retreg2
Condit. Reinf. active minus inactive responses 7271.32 2 2 50 0 1.00e+00 Mst1 Retreg2
Condit. Reinf. active-inactive response ratio 14360.59 2 1 25 0 1.00e+00 Ndufb9 Retreg2
Condit. Reinf. active responses 1165.18 2 2 50 0 1.00e+00 Mst1 Retreg2
Condit. Reinf. inactive responses 5466.41 2 2 50 0 1.00e+00 Mst1 Retreg2
Condit. Reinf. lever presses 1311.07 3 2 50 0 1.00e+00 Mst1 Ndufb9 Retreg2
Condit. Reinf. lever reinforcers received 243.91 2 1 25 0 1.00e+00 Mst1 Retreg2
Pavlov. Cond. lever latency 1278.33 2 2 50 0 1.00e+00 Mst1 Retreg2
Pavlov. Cond. magazine entry latency 6738.25 2 2 50 0 1.00e+00 Mst1 Retreg2
Pavlov. Cond. change in total contacts 19909.31 2 1 25 0 1.00e+00 Ndufb9 Retreg2
Pavlov. Cond. index score 6407.33 2 2 50 0 1.00e+00 Mst1 Retreg2
Pavlov. Cond. latency score 8109.24 2 2 50 0 1.00e+00 Mst1 Retreg2
Pavlov. Cond. lever contacts 2689.72 2 2 50 0 1.00e+00 Mst1 Retreg2
Pavlov. Cond. magazine entry number 2097.69 2 2 50 0 1.00e+00 Mst1 Retreg2
Pavlov. Cond. intertrial magazine entries 17558.57 2 2 50 0 1.00e+00 Mst1 Retreg2
Pavlov. Cond. lever-magazine prob. diff. 5938.34 2 2 50 0 1.00e+00 Mst1 Retreg2
Pavlov. Cond. response bias 641.31 2 2 50 0 1.00e+00 Mst1 Retreg2
Conditioned reinforcement - actives 33617.26 3 2 50 0 1.00e+00 Ccny Ndufb9 Retreg2
Conditioned reinforcement - inactives 16265.43 4 3 75 -0.99 6.22e-03 Ccny Mst1 Ndufb9 Retreg2
Conditioned locomotion 2608.24 4 2 50 -1 2.54e-03 Ccny Mst1 Ndufb9 Retreg2
Intermittent access intake day 1-15 change 42631.78 3 2 50 0 1.00e+00 Ccny Mst1 Retreg2
Intermittent access intake escalation 63041.23 2 2 50 0 1.00e+00 Mst1 Retreg2
Intermittent access intake escalation 2 12071.47 3 2 50 0 1.00e+00 Ccny Mst1 Retreg2
Intermitt. access day 1 inactive lever presses 45173.91 4 2 50 -1 3.04e-03 Ccny Mst1 Ndufb9 Retreg2
Intermitt. access day 15 inactive lever presses 61868.22 2 2 50 0 1.00e+00 Ndufb9 Retreg2
Intermitt. access escalation Index 31137.19 3 2 50 0 1.00e+00 Mst1 Ndufb9 Retreg2
Intermittent access day 1 total infusions 33063.01 2 1 25 0 1.00e+00 Mst1 Retreg2
Intermittent access day 15 total infusions 48731.91 1 1 25 0 1.00e+00 Retreg2
Intermittent access terminal intake (last 3 days) 24800.59 1 1 25 0 1.00e+00 Retreg2
Intermittent access total infusions 93.49 2 1 25 0 1.00e+00 Ccny Retreg2
Intermittent access day 1 locomotion 17487.55 2 1 25 0 1.00e+00 Ccny Retreg2
Intermittent access day 15 total locomotion 42786.58 2 2 50 0 1.00e+00 Ccny Retreg2
Intermittent access total locomotion 45.91 3 1 25 0 1.00e+00 Mst1 Ndufb9 Retreg2
Intermittent access standard deviation 38004.24 3 3 75 0 1.00e+00 Ccny Mst1 Retreg2
Cocaine induced anxiety 23063.21 3 2 50 0 1.00e+00 Ccny Ndufb9 Retreg2
Post-drug Anxiety 1595.89 3 2 50 0 1.00e+00 Mst1 Ndufb9 Retreg2
Baseline Anxiety 11242.19 3 2 50 0 1.00e+00 Ccny Ndufb9 Retreg2
Lifetime Intake 834.23 2 1 25 0 1.00e+00 Ccny Retreg2
Incentive Sensitization - Responses 23798.01 3 2 50 0 1.00e+00 Ccny Ndufb9 Retreg2
Incentive Sensitization - Breakpoint 18436.14 3 2 50 0 1.00e+00 Ccny Ndufb9 Retreg2
Progressive ratio test 1 active lever presses 10671 3 1 25 0 1.00e+00 Ccny Ndufb9 Retreg2
Progressive ratio test 1 breakpoint 10109.49 3 1 25 0 1.00e+00 Ccny Ndufb9 Retreg2
Progressive ratio test 1 inactive lever presses 20756.82 3 3 75 0 1.00e+00 Mst1 Ndufb9 Retreg2
Progressive ratio test 2 active lever presses 5096.01 3 1 25 0 1.00e+00 Ccny Ndufb9 Retreg2
Progressive ratio test 2 breakpoint 2856.35 3 1 25 0 1.00e+00 Ccny Ndufb9 Retreg2
Progressive ratio test 2 inactive lever presses 18130.29 4 1 25 -1 2.58e-03 Ccny Mst1 Ndufb9 Retreg2
Total sessions with >9 infusions 678.23 3 3 75 0 1.00e+00 Ccny Mst1 Retreg2
Short access day 1 total inactive lever presses 9884.94 4 3 75 1 4.48e-03 Ccny Mst1 Ndufb9 Retreg2
Short access day 10 total inactive lever presses 46316.52 3 3 75 0 1.00e+00 Ccny Mst1 Retreg2
Short access day 1 total infusions 12825.11 3 2 50 0 1.00e+00 Ccny Mst1 Retreg2
Short access day 10 total infusions 7585.44 3 3 75 0 1.00e+00 Mst1 Ndufb9 Retreg2
Short access total infusions 4403.04 2 2 50 0 1.00e+00 Ccny Retreg2
Short access day 1 locomotion 6216.13 4 2 50 -1 4.75e-03 Ccny Mst1 Ndufb9 Retreg2
Short access day 10 total locomotion 44094.34 2 1 25 0 1.00e+00 Mst1 Retreg2
Short access total locomotion 6239.96 3 2 50 0 1.00e+00 Mst1 Ndufb9 Retreg2
Compulsive drug intake 6234.79 3 1 25 0 1.00e+00 Mst1 Ndufb9 Retreg2
One hour access (0.3 mA shock) 781.33 3 1 25 0 1.00e+00 Ccny Ndufb9 Retreg2
One hour access (shock baseline) 54988.81 1 1 25 0 1.00e+00 Retreg2
Number of responses in last shaping day 4550.18 3 1 25 0 1.00e+00 Ccny Mst1 Retreg2
Context. condit. distance diff. score 212.47 1 1 25 0 1.00e+00 Retreg2
Locomotion velocity, session 1 1769.63 2 1 25 0 1.00e+00 Ndufb9 Retreg2
Locomotion distance, session 1 516.6 2 1 25 0 1.00e+00 Ccny Retreg2
Locomotion velocity, session 2 1110.36 2 2 50 0 1.00e+00 Mst1 Retreg2
Locomotion distance, session 2 174.93 3 1 25 0 1.00e+00 Ccny Mst1 Retreg2
Locomotion velocity, session 3 507.49 1 1 25 0 1.00e+00 Retreg2
Locomotion distance, session 3 4009.46 1 1 25 0 1.00e+00 Retreg2
Stereotopy head waving bouts, day 3 691.91 2 1 25 0 1.00e+00 Mst1 Retreg2
Stereotopy head waving duration, day 3 1446.08 2 1 25 0 1.00e+00 Mst1 Retreg2
Locomotion velocity, session 7 210.64 2 2 50 0 1.00e+00 Mst1 Retreg2
Locomotion distance, session 7 342.68 3 2 50 0 1.00e+00 Mst1 Ndufb9 Retreg2
Stereotopy head waving bouts, day 7 1279.33 2 2 50 0 1.00e+00 Ndufb9 Retreg2
Stereotopy head waving duration, day 7 1081.37 2 2 50 0 1.00e+00 Ndufb9 Retreg2
Locomotion velocity, session 8 409.23 1 1 25 0 1.00e+00 Retreg2
Locomotion distance, session 8 147.88 1 1 25 0 1.00e+00 Retreg2
Degree of sensitization distance 1889.61 2 2 50 0 1.00e+00 Mst1 Retreg2
Degree of sensitization stereotypy 690.43 3 1 25 0 1.00e+00 Mst1 Ndufb9 Retreg2
Condit. Reinf. active minus inactive responses 957.65 1 1 25 0 1.00e+00 Retreg2
Condit. Reinf. active-inactive response ratio 242.03 1 1 25 0 1.00e+00 Retreg2
Condit. Reinf. active responses 2765.7 1 1 25 0 1.00e+00 Retreg2
Condit. Reinf. inactive responses 1569.87 3 1 25 0 1.00e+00 Mst1 Ndufb9 Retreg2
Incentive salience index mean 1780.77 2 1 25 0 1.00e+00 Mst1 Retreg2
Condit. Reinf. lever presses 2666.81 2 2 50 0 1.00e+00 Mst1 Retreg2
Time in familiar zone, hab. session 1 5593.23 2 1 25 0 1.00e+00 Mst1 Retreg2
Time in novel zone, hab. session 1 4629.95 2 2 50 0 1.00e+00 Mst1 Retreg2
Total zone transitions, hab. session 1 221.7 2 1 25 0 1.00e+00 Ndufb9 Retreg2
Total locomotion distance, hab. session 1 394.1 1 1 25 0 1.00e+00 Retreg2
Locomotion velocity, hab. session 1 266.96 1 1 25 0 1.00e+00 Retreg2
Time in familiar zone, hab. session 2 2966.16 2 2 50 0 1.00e+00 Mst1 Retreg2
Time in novel zone, hab. session 2 3208.33 2 2 50 0 1.00e+00 Mst1 Retreg2
Total zone transitions, hab. session 2 28.15 3 1 25 0 1.00e+00 Mst1 Ndufb9 Retreg2
Total locomotion distance, hab. session 2 14.23 2 1 25 0 1.00e+00 Mst1 Retreg2
Locomotion velocity, hab. session 2 31.27 1 1 25 0 1.00e+00 Retreg2
Novel to familiar place preference ratio 5121.06 3 1 25 0 1.00e+00 Ccny Mst1 Retreg2
Novelty place preference 7474.7 2 1 25 0 1.00e+00 Mst1 Retreg2
Time in novel zone, NPP test 5350.34 2 1 25 0 1.00e+00 Mst1 Retreg2
Total zone transitions, NPP test 980.79 2 2 50 0 1.00e+00 Ndufb9 Retreg2
Total locomotion distance, NPP test 1687.31 1 1 25 0 1.00e+00 Retreg2
Locomotion velocity, NPP test 479.14 2 1 25 0 1.00e+00 Ccny Retreg2
Pavlov. Cond. lever latency 186.46 3 2 50 0 1.00e+00 Mst1 Ndufb9 Retreg2
Pavlov. Cond. change in total contacts 522.83 2 1 25 0 1.00e+00 Mst1 Retreg2
Pavlov. Cond. index score 214.07 2 2 50 0 1.00e+00 Mst1 Retreg2
Pavlov. Cond. latency score 224.45 2 2 50 0 1.00e+00 Mst1 Retreg2
Pavlov. Cond. lever contacts 252.4 3 2 50 0 1.00e+00 Mst1 Ndufb9 Retreg2
Pavlov. Cond. magazine entry number 250.94 2 1 25 0 1.00e+00 Mst1 Retreg2
Pavlov. Cond. intertrial magazine entries 60.1 3 2 50 0 1.00e+00 Mst1 Ndufb9 Retreg2
Pavlov. Cond. lever-magazine prob. diff. 223.77 2 2 50 0 1.00e+00 Mst1 Retreg2
Pavlov. Cond. response bias 303.26 2 2 50 0 1.00e+00 Mst1 Retreg2
Bone: apparent density 2735.95 2 1 25 0 1.00e+00 Ndufb9 Retreg2
Bone surface 3109.3 2 2 50 0 1.00e+00 Mst1 Retreg2
Bone volume 4317.38 2 1 25 0 1.00e+00 Mst1 Retreg2
Bone: connectivity density 564.06 3 1 25 0 1.00e+00 Mst1 Ndufb9 Retreg2
Bone: cortical apparent density 6014.36 2 1 25 0 1.00e+00 Ndufb9 Retreg2
Bone: cortical area 1559.21 3 2 50 0 1.00e+00 Mst1 Ndufb9 Retreg2
Bone: cortical porosity 150.35 3 1 25 0 1.00e+00 Mst1 Ndufb9 Retreg2
Bone: cortical porosity 560.57 2 1 25 0 1.00e+00 Ndufb9 Retreg2
Bone: cortical thickness 157.6 3 2 50 0 1.00e+00 Mst1 Ndufb9 Retreg2
Bone: cortical thickness 996.09 3 2 50 0 1.00e+00 Mst1 Ndufb9 Retreg2
Bone: cortical tissue density 4339.01 3 1 25 0 1.00e+00 Mst1 Ndufb9 Retreg2
Bone: elastic displacement 7604.03 1 1 25 0 1.00e+00 Retreg2
Bone: elastic work 195.81 2 2 50 0 1.00e+00 Mst1 Retreg2
Bone: endosteal estimation 2975.35 3 1 25 0 1.00e+00 Mst1 Ndufb9 Retreg2
Bone: endosteal perimeter 5936.33 2 1 25 0 1.00e+00 Mst1 Retreg2
Bone: final force 840.18 2 2 50 0 1.00e+00 Mst1 Retreg2
Bone: final moment 146.88 2 2 50 0 1.00e+00 Mst1 Retreg2
Bone: marrow area 3148.45 3 1 25 0 1.00e+00 Mst1 Ndufb9 Retreg2
Bone: maximum diameter 2046.98 3 2 50 0 1.00e+00 Mst1 Ndufb9 Retreg2
Bone: maximum force 4390.32 2 2 50 0 1.00e+00 Mst1 Retreg2
Bone: maximum moment 2024.32 3 2 50 0 1.00e+00 Mst1 Ndufb9 Retreg2
Bone: minimum diameter 2061.38 2 2 50 0 1.00e+00 Mst1 Retreg2
Bone: periosteal estimation 4919.52 2 2 50 0 1.00e+00 Mst1 Retreg2
Bone: periosteal perimeter 5722.93 2 2 50 0 1.00e+00 Mst1 Retreg2
Bone: post-yield work 6843.13 2 1 25 0 1.00e+00 Mst1 Retreg2
Bone: stiffness 4554.23 2 2 50 0 1.00e+00 Mst1 Retreg2
Bone: tissue strength 2995.95 1 1 25 0 1.00e+00 Retreg2
Bone: trabecular number 5387.39 2 2 50 0 1.00e+00 Ndufb9 Retreg2
Bone: trabecular spacing 2669.39 3 3 75 0 1.00e+00 Mst1 Ndufb9 Retreg2
Bone: trabecular thickness 4257.4 2 2 50 0 1.00e+00 Mst1 Retreg2
Bone: trabecular tissue density 4866.8 3 3 75 0 1.00e+00 Mst1 Ndufb9 Retreg2
LgA early post infusion interval 17807.67 3 3 75 0 1.00e+00 Ccny Ndufb9 Retreg2
LgA late post infusion interval 11653.15 3 2 50 0 1.00e+00 Mst1 Ndufb9 Retreg2
LgA early loading 54570.01 2 1 25 0 1.00e+00 Ndufb9 Retreg2
LgA late loading 46428.54 3 2 50 0 1.00e+00 Ccny Ndufb9 Retreg2
LgA early average infusions 9746.6 3 1 25 0 1.00e+00 Ccny Ndufb9 Retreg2
LgA late average infusions 31550.62 2 2 50 0 1.00e+00 Ndufb9 Retreg2
LgA early timeout 12057.77 1 1 25 0 1.00e+00 Retreg2
LgA late timeout 19618.34 3 1 25 0 1.00e+00 Mst1 Ndufb9 Retreg2
LgA early titration 31242.14 2 2 50 0 1.00e+00 Ndufb9 Retreg2
LgA late titration 22568.78 3 3 75 0 1.00e+00 Mst1 Ndufb9 Retreg2
LgA total infusion 13538.04 3 2 50 0 1.00e+00 Ccny Ndufb9 Retreg2
LgA PC1 addiction-like behavior 52579.61 2 2 50 0 1.00e+00 Ndufb9 Retreg2
ShA PR total presses 11213.89 2 1 25 0 1.00e+00 Ndufb9 Retreg2
LgA PR total presses 3281.01 2 2 50 0 1.00e+00 Ccny Retreg2
ShA early post infusion interval 8072.47 1 1 25 0 1.00e+00 Retreg2
ShA late post infusion interval 86.39 4 1 25 0.89 1.06e-01 Ccny Mst1 Ndufb9 Retreg2
ShA early loading 57.13 4 2 50 0.98 1.76e-02 Ccny Mst1 Ndufb9 Retreg2
ShA late loading 28379.36 2 1 25 0 1.00e+00 Ndufb9 Retreg2
ShA early average infusions 4887.59 4 4 100 1 2.15e-03 Ccny Mst1 Ndufb9 Retreg2
ShA late average infusions 4442.59 2 1 25 0 1.00e+00 Ndufb9 Retreg2
ShA early timeout 156.31 4 2 50 0.98 2.33e-02 Ccny Mst1 Ndufb9 Retreg2
ShA late timeout 9217.96 2 1 25 0 1.00e+00 Mst1 Retreg2
ShA late titration 3826.49 3 1 25 0 1.00e+00 Ccny Ndufb9 Retreg2
ShA total infusions 18638.92 2 1 25 0 1.00e+00 Ndufb9 Retreg2
Shock compulsivity 58902.44 2 2 50 0 1.00e+00 Ccny Retreg2
Total infusions 9598.69 3 2 50 0 1.00e+00 Ccny Ndufb9 Retreg2
Breakpoint value in progressive ratio session 18809.48 2 1 25 0 1.00e+00 Mst1 Retreg2
Distance traveled before self-admin 12640.31 4 1 25 -1 1.04e-03 Ccny Mst1 Ndufb9 Retreg2
Distance traveled after self-admin 16247.09 2 2 50 0 1.00e+00 Ccny Retreg2
Delta time in closed arm before/after self-admin 98.8 4 2 50 -0.89 1.14e-01 Ccny Mst1 Ndufb9 Retreg2
Delta time in open arm before/after self-admin 5049.67 3 1 25 0 1.00e+00 Ccny Mst1 Retreg2
Diff in mean of infusions in LGA sessions 12226.72 3 2 50 0 1.00e+00 Mst1 Ndufb9 Retreg2
Extinction: sum of active levers before priming 7131.77 4 4 100 -1 2.91e-03 Ccny Mst1 Ndufb9 Retreg2
Active lever presses in extinction session 6 272.24 3 3 75 0 1.00e+00 Ccny Mst1 Retreg2
Delta distance traveled before/after self-admin 996.98 3 2 50 0 1.00e+00 Ccny Ndufb9 Retreg2
Delta ambulatory time before/after self-admin 10288.96 3 1 25 0 1.00e+00 Ccny Ndufb9 Retreg2
Time in closed arm before self-admin 8974 3 2 50 0 1.00e+00 Ccny Mst1 Retreg2
Time in closed arm after self-admin 1570.76 3 3 75 0 1.00e+00 Ccny Mst1 Retreg2
Time in open arm before self-admin 2213.9 4 3 75 0.98 1.55e-02 Ccny Mst1 Ndufb9 Retreg2
Time in open arm after self-admin 152.24 4 3 75 -0.84 1.63e-01 Ccny Mst1 Ndufb9 Retreg2
Sum of active levers in priming session hrs 5-6 496.26 2 1 25 0 1.00e+00 Ndufb9 Retreg2
Time to tail flick, vehicle, before self-admin 3376.29 4 3 75 -1 5.56e-04 Ccny Mst1 Ndufb9 Retreg2
Time to tail flick, vehicle, after self-admin 14057.72 3 1 25 0 1.00e+00 Ccny Ndufb9 Retreg2
Time to tail flick, test, before self-admin 2731.5 3 2 50 0 1.00e+00 Mst1 Ndufb9 Retreg2
Time to tail flick, test, after self-admin 377.49 4 2 50 -0.97 3.21e-02 Ccny Mst1 Ndufb9 Retreg2
Delta time to tail flick, vehicle, before/after SA 3305.45 3 3 75 0 1.00e+00 Ccny Mst1 Retreg2
Delta time to tail flick, test, before/after SA 5236.1 3 1 25 0 1.00e+00 Mst1 Ndufb9 Retreg2
Ambulatory time before self-admin 39445.74 2 1 25 0 1.00e+00 Ccny Retreg2
Ambulatory time after self-admin 8880.01 3 1 25 0 1.00e+00 Ccny Mst1 Retreg2
Total heroin consumption 134.58 2 2 50 0 1.00e+00 Ccny Retreg2
Area under the delay curve 24791.27 1 1 25 0 1.00e+00 Retreg2
Delay disc. indifference point, 0s delay 2159.25 1 1 25 0 1.00e+00 Retreg2
Delay disc. indifference point, 16s delay 10986.22 2 1 25 0 1.00e+00 Ccny Retreg2
Delay disc. indifference point, 2s delay 155.27 1 1 25 0 1.00e+00 Retreg2
Delay disc. indifference point, 24s delay 16227.16 2 1 25 0 1.00e+00 Ccny Retreg2
Delay disc. indifference point, 4s delay 162.94 4 1 25 1 2.29e-03 Ccny Mst1 Ndufb9 Retreg2
Delay disc. indifference point, 8s delay 33362.4 1 1 25 0 1.00e+00 Retreg2
Delay discount exponential model param 16922.54 1 1 25 0 1.00e+00 Retreg2
Delay discount hyperbolic model param 12277.65 1 1 25 0 1.00e+00 Retreg2
Fecal boli incidents, locomotor time 1 61202.36 1 1 25 0 1.00e+00 Retreg2
Change in fecal boli incidents, locomotor task 1914.03 3 3 75 0 1.00e+00 Ccny Ndufb9 Retreg2
Time >=10cm from walls, locomotor time 1 4342.59 3 1 25 0 1.00e+00 Ccny Ndufb9 Retreg2
Bouts of movement, locomotor time 1 3607.99 3 2 50 0 1.00e+00 Ccny Ndufb9 Retreg2
Total resting periods, locomotor time 1 1407.78 2 1 25 0 1.00e+00 Ccny Retreg2
Rest time, locomotor task time 1 11183.83 2 1 25 0 1.00e+00 Ndufb9 Retreg2
Distance moved, locomotor task time 1 22964.53 3 2 50 0 1.00e+00 Ccny Ndufb9 Retreg2
Vertical activity count, locomotor time 1 142354.07 1 1 25 0 1.00e+00 Retreg2
Time >=10cm from walls, locomotor time 2 35582.77 2 1 25 0 1.00e+00 Ccny Retreg2
Bouts of movement, locomotor time 2 41025.7 2 2 50 0 1.00e+00 Ccny Retreg2
Total resting periods, locomotor time 2 49531.53 2 2 50 0 1.00e+00 Ccny Retreg2
Rest time, locomotor task time 2 12756.26 2 1 25 0 1.00e+00 Ndufb9 Retreg2
Distance moved, locomotor task time 2 2835.6 3 2 50 0 1.00e+00 Ccny Ndufb9 Retreg2
Vertical activity count, locomotor time 2 26786.04 2 1 25 0 1.00e+00 Ccny Retreg2
Weight adjusted by age 23619.48 3 3 75 0 1.00e+00 Ccny Ndufb9 Retreg2
Seeking ratio, delayed vs. immediate footshock 6729.38 2 1 25 0 1.00e+00 Ccny Retreg2
Locomotion in novel chamber 1330.8 3 2 50 0 1.00e+00 Ccny Ndufb9 Retreg2
Locomotion in novel chamber post-restriction 21811.49 3 1 25 0 1.00e+00 Ccny Ndufb9 Retreg2
Progressive ratio 22651.13 3 3 75 0 1.00e+00 Ccny Ndufb9 Retreg2
Food seeking constrained by brief footshock 941.83 2 1 25 0 1.00e+00 Ndufb9 Retreg2
Seeking ratio, punishment vs. effort 13770.59 3 2 50 0 1.00e+00 Ccny Ndufb9 Retreg2
Run reversals in cocaine runway, females 9406.04 1 1 25 0 1.00e+00 Retreg2
Run reversals in cocaine runway, males 3884.61 2 2 50 0 1.00e+00 Ndufb9 Retreg2
Latency to leave start box in cocaine runway 8153.9 2 1 25 0 1.00e+00 Ccny Retreg2
Latency to leave start box in cocaine runway, F 3596.44 2 2 50 0 1.00e+00 Ndufb9 Retreg2
Latency to leave start box in cocaine runway, M 593.09 3 2 50 0 1.00e+00 Ccny Ndufb9 Retreg2
Co content in liver 1133.25 1 1 25 0 1.00e+00 Retreg2
Cu content in liver 28.08 2 1 25 0 1.00e+00 Ndufb9 Retreg2
Fe content in liver 1344.53 1 1 25 0 1.00e+00 Retreg2
K content in liver 1519.62 1 1 25 0 1.00e+00 Retreg2
Mg content in liver 6026.97 1 1 25 0 1.00e+00 Retreg2
Mn content in liver 537.3 2 2 50 0 1.00e+00 Ndufb9 Retreg2
Na content in liver 2013.84 2 1 25 0 1.00e+00 Ndufb9 Retreg2
Rb content in liver 71.08 2 2 50 0 1.00e+00 Ndufb9 Retreg2
Se content in liver 8.63 1 0 0 0 1.00e+00 Ndufb9
Zn content in liver 1887.46 2 2 50 0 1.00e+00 Ndufb9 Retreg2

Associations by panel

Tissue RNA modality # hits % hits/tests Avg chisq
Adipose alternative polyA 0 0 1.13
Adipose alternative TSS 0 0 1.1
Adipose gene expression 0 0 1.12
Adipose isoform ratio 0 0 1.1
Adipose intron excision ratio 0 0 0.99
Adipose mRNA stability 1 0 1.08
BLA alternative polyA 0 0 1.15
BLA alternative TSS 0 0 1.04
BLA gene expression 0 0 1.11
BLA isoform ratio 0 0 1.05
BLA intron excision ratio 0 0 1.05
BLA mRNA stability 0 0 1.09
Brain alternative polyA 0 0 1.14
Brain alternative TSS 0 0 1.09
Brain gene expression 0 0 1.12
Brain isoform ratio 0 0 1.11
Brain intron excision ratio 0 0 1.03
Brain mRNA stability 0 0 1.12
Eye alternative polyA 0 0 1.25
Eye alternative TSS 0 0 1
Eye gene expression 0 0 1.01
Eye isoform ratio 0 0 1.06
Eye intron excision ratio 0 0 1.01
Eye mRNA stability 0 0 0.99
IC alternative polyA 0 0 1.11
IC alternative TSS 0 0 1.12
IC gene expression 0 0 1.15
IC isoform ratio 0 0 1.11
IC intron excision ratio 0 0 1.03
IC mRNA stability 0 0 1.12
IL alternative polyA 0 0 1.08
IL alternative TSS 0 0 1.06
IL gene expression 0 0 1.13
IL isoform ratio 0 0 1.13
IL intron excision ratio 0 0 0.95
IL mRNA stability 0 0 1.09
LHb alternative polyA 0 0 1.12
LHb alternative TSS 0 0 1.07
LHb gene expression 0 0 1.08
LHb isoform ratio 0 0 1.08
LHb intron excision ratio 0 0 1.04
LHb mRNA stability 0 0 1.09
Liver alternative polyA 0 0 1.14
Liver alternative TSS 0 0 1.07
Liver gene expression 0 0 1.13
Liver isoform ratio 1 0 1.11
Liver intron excision ratio 0 0 1.1
Liver mRNA stability 0 0 1.12
NAcc alternative polyA 1 0 1.56
NAcc alternative TSS 0 0 1.09
NAcc gene expression 0 0 1.14
NAcc isoform ratio 0 0 1.13
NAcc intron excision ratio 0 0 1.07
NAcc mRNA stability 0 0 1.12
OFC alternative polyA 0 0 1.22
OFC alternative TSS 0 0 1.04
OFC gene expression 0 0 1.12
OFC isoform ratio 0 0 1.17
OFC intron excision ratio 0 0 1.04
OFC mRNA stability 0 0 1.09
PL alternative polyA 0 0 1.15
PL alternative TSS 0 0 1.09
PL gene expression 0 0 1.14
PL isoform ratio 0 0 1.1
PL intron excision ratio 0 0 1.07
PL mRNA stability 0 0 1.15
pVTA alternative polyA 0 0 1.18
pVTA alternative TSS 0 0 1.12
pVTA gene expression 1 0 1.13
pVTA isoform ratio 0 0 1.11
pVTA intron excision ratio 0 0 1.03
pVTA mRNA stability 0 0 1.13
RMTg alternative polyA 0 0 1.06
RMTg alternative TSS 0 0 1.15
RMTg gene expression 0 0 1.1
RMTg isoform ratio 0 0 1.13
RMTg intron excision ratio 0 0 1.04
RMTg mRNA stability 0 0 1.1